Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne L Taylor

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of the American College of Cardiology|September 19, 2006
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT TrialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 29, 2007
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure TrialJalal K Ghali, S William Tam, Keith C Ferdinand, et al.
Journal of the American College of Cardiology|December 13, 2006
Outcomes by gender in the African-American Heart Failure TrialAnne L Taylor, JoAnn Lindenfeld, Susan Ziesche, et al.
Ethnicity & Disease|April 26, 2017
Development and Evaluation of Two Abbreviated Questionnaires for Mentoring and Research Self-EfficacyDonna B Jeffe, Treva K Rice, Josephine E A Boyington, et al.
Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.
Journal of Women'S Health (2002)|July 2, 2010
Outcomes of comprehensive heart care programs in high-risk womenAmparo C Villablanca, Laurel A Beckett, Yueju Li, et al.
Journal of Cardiac Failure|September 18, 2017
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure TrialKay-Won Chang, Neil Beri, Nghia H Nguyen, et al.
Circulation|March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure TrialAnne L Taylor, Susan Ziesche, Clyde W Yancy, et al.
Journal of Cardiac Failure|March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 8, 2014
Does structured patient education improve the recovery and clinical outcomes of patients with neck pain? A systematic review from the Ontario Protocol for Traffic Injury Management (OPTIMa) CollaborationHainan Yu, Pierre Côté, Danielle Southerst, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of the American College of Cardiology|September 19, 2006
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT TrialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 29, 2007
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure TrialJalal K Ghali, S William Tam, Keith C Ferdinand, et al.
Journal of the American College of Cardiology|December 13, 2006
Outcomes by gender in the African-American Heart Failure TrialAnne L Taylor, JoAnn Lindenfeld, Susan Ziesche, et al.
Ethnicity & Disease|April 26, 2017
Development and Evaluation of Two Abbreviated Questionnaires for Mentoring and Research Self-EfficacyDonna B Jeffe, Treva K Rice, Josephine E A Boyington, et al.
Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.
Journal of Women'S Health (2002)|July 2, 2010
Outcomes of comprehensive heart care programs in high-risk womenAmparo C Villablanca, Laurel A Beckett, Yueju Li, et al.
Journal of Cardiac Failure|September 18, 2017
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure TrialKay-Won Chang, Neil Beri, Nghia H Nguyen, et al.
Circulation|March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure TrialAnne L Taylor, Susan Ziesche, Clyde W Yancy, et al.
Journal of Cardiac Failure|March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 8, 2014
Does structured patient education improve the recovery and clinical outcomes of patients with neck pain? A systematic review from the Ontario Protocol for Traffic Injury Management (OPTIMa) CollaborationHainan Yu, Pierre Côté, Danielle Southerst, et al.
Pageof 6